Stocks › INSM
INSMED Inc
INSM·Nasdaq·
United States·USD
$141.33
-3.13 (-2.17%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
INSM
INSMED Inc · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INSMS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of INSM by members of U.S. Congress · 10 on record · 1 in the last 12 months
Whale Activity
Position changes in INSM reported for 2026-09-30 by 787 institutional filers
- Increased264
- New120
- Held75
- Decreased212
- Closed81
- No prior filing35
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 15.9M | $1.82B | increased |
| FMR LLC | 15.5M | $1.77B | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 10.5M | $1.20B | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.8M | $1.12B | increased |
| Capital International Investors | 9.4M | $1.07B | increased |
| BAKER BROS. ADVISORS LP | 8.8M | $1.00B | held |
| JPMORGAN CHASE & CO | 8.2M | $953.2M | decreased |
| Orbis Allan Gray Ltd | 6.7M | $768.6M | increased |
| AMERIPRISE FINANCIAL INC | 6.3M | $713.5M | — |
| STATE STREET CORP | 6.2M | $703.4M | increased |
| Artisan Partners Limited Partnership | 5.6M | $636.7M | increased |
| AQR CAPITAL MANAGEMENT LLC | 5.2M | $594.6M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by INSM insiders, by quarter · Form 4
Recent Insider Transactions
1,340 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Schaeffer Orlov S NicoleChief People Strategy Officer | Sale | −90.3K | $145.06 | $13.1M | Nov 19, 2026 | Form 4 ↗ |
| Schaeffer Orlov S NicoleChief People Strategy Officer | Sale | −8,539 | $146.76 | $1.3M | Nov 19, 2026 | Form 4 ↗ |
| Schaeffer Orlov S NicoleChief People Strategy Officer | Sale | −2,262 | $147.50 | $334K | Nov 19, 2026 | Form 4 ↗ |
| Brennan David RDirector | Sale | −25.0K | $124.00 | $3.1M | Sep 9, 2026 | Form 4 ↗ |
| SHAROKY MELVIN MDDirector | Sale | −5,000 | $127.53 | $638K | Aug 17, 2026 | Form 4 ↗ |
| Adsett RogerChief Operating Officer | Sale | −239.8K | $133.27 | $32.0M | Aug 10, 2026 | Form 4 ↗ |
| Adsett RogerChief Operating Officer | Option exercise | +81.0K | $30.46 | $2.5M | Aug 10, 2026 | Form 4 ↗ |
| Adsett RogerChief Operating Officer | Option exercise | +76.6K | $17.16 | $1.3M | Aug 10, 2026 | Form 4 ↗ |
| Adsett RogerChief Operating Officer | Option exercise | +82.3K | $13.67 | $1.1M | Aug 10, 2026 | Form 4 ↗ |
| Flammer Martina M.D.Chief Medical Officer | Sale | −18.3K | $129.40 | $2.4M | Aug 6, 2026 | Form 4 ↗ |
| Flammer Martina M.D.Chief Medical Officer | Sale | −8,895 | $127.00 | $1.1M | Aug 6, 2026 | Form 4 ↗ |
| Flammer Martina M.D.Chief Medical Officer | Option exercise | +8,895 | $25.83 | $230K | Aug 6, 2026 | Form 4 ↗ |
| Flammer Martina M.D.Chief Medical Officer | Option exercise | +18.3K | $18.95 | $346K | Aug 6, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Sale | −5,872 | $106.43 | $625K | Jul 23, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Sale | −4,828 | $105.62 | $510K | Jul 23, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Option exercise | +4,440 | $17.16 | $76K | Jul 23, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Option exercise | +6,260 | $30.46 | $191K | Jul 23, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Sale | −3,359 | $118.52 | $398K | Jul 9, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Sale | −2,335 | $117.62 | $275K | Jul 9, 2026 | Form 4 ↗ |
| Lewis WilliamChair and CEO · Director | Sale | −5,005 | $116.55 | $583K | Jul 9, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding INSM · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Growth Fund of America | 6.8M | $822.4M | 0.23% | Aug 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 6.9M | $734.0M | 0.03% | Jun 30, 2026 |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 2.8M | $297.5M | 0.24% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.5M | $265.1M | 0.14% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.5M | $265.0M | 0.27% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.3M | $250.4M | 0.11% | Jun 30, 2026 |
| Fidelity Advisor Growth Opportunities Fund Fidelity Advisor Series I | 1.7M | $201.4M | 0.59% | Aug 31, 2026 |
| VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.8M | $192.3M | 0.05% | Jun 30, 2026 |
| iShares Biotechnology ETF iShares Trust | 1.5M | $162.2M | 1.78% | Jun 30, 2026 |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 1.4M | $152.9M | 1.16% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list INSM's shares (CUSIP 457669307), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Darwin Global Master Fund, Ltd.SCHEDULE 13G/A · passive (13G) · 6.3M shares2.9%
Aug 14, 2026 · ↗ - Dr. Abhishek TrehanSCHEDULE 13G/A · passive (13G) · 6.4M shares3.0%
Aug 14, 2026 · ↗ - Darwin Global Management, Ltd.SCHEDULE 13G/A · passive (13G) · 6.4M shares3.0%
Aug 14, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 16.1M shares7.4%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 16.1M shares7.4%
Aug 6, 2026 · ↗ - JPMORGAN CHASE & CO.SCHEDULE 13G/A · passive (13G) · 10.4M shares4.7%
Jul 22, 2026 · ↗ - Darwin Global Master Fund, Ltd.SCHEDULE 13G/A · passive (13G) · 14.2M shares6.6%
May 15, 2026 · ↗ - Dr. Abhishek TrehanSCHEDULE 13G/A · passive (13G) · 16.8M shares7.8%
May 15, 2026 · ↗ - Darwin Global Management, Ltd.SCHEDULE 13G/A · passive (13G) · 16.8M shares7.8%
May 15, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 13.1M shares6.1%
May 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming insmed as client
- LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q3 · TRD$50K
Filing ↗ - JEFFREY J. KIMBELL & ASSOCIATES, INC.INSMED, INC. · 2026 Q3 · HCR, MMM$10K
Filing ↗ - JEFFREY J. KIMBELL & ASSOCIATES, INC.INSMED, INC. · 2026 Q2 · HCR, MMM$10K
Filing ↗ - LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q2 · TRD$20K
Filing ↗ - LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q2 · TRD—
Filing ↗
Government Contracts
Federal awards to insmed · USAspending
$31KAwarded · 1 contract on record
- Department of Veterans AffairsREZDIFFRA 80 MG$31K
Jun 10, 2026 · ↗
U.S. Patents
Recent USPTO applications naming INSMED Inc
No USPTO patent applications found for INSMED Inc.
Annual Financials
From INSM's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $606.4M | $363.7M | $305.2M | $245.4M | $188.5M |
| Operating income | -$1.25B | -$878.3M | -$709.6M | -$457.3M | -$375.1M |
| Net income | -$1.28B | -$913.8M | -$749.6M | -$481.5M | -$434.7M |
| Diluted EPS | -$6.42 | -$5.57 | -$5.34 | -$3.91 | -$3.88 |
| Operating cash flow | -$935.0M | -$683.9M | -$536.2M | -$400.4M | -$363.3M |
| Cash and equivalents | $510.4M | $555.0M | $482.4M | $1.07B | $716.8M |
| Total assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B |
| Total liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833.0M |
| Shareholders' equity | $739.0M | $285.4M | -$331.9M | $88.0M | $410.5M |
As INSMED Inc tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 1-for-10Reverse splitMar 3, 2011
- 1-for-4Reverse splitJul 31, 2000
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 9.01Results of operationsOct 29, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 20, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 5, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJul 16, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 15, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
EDGAR ↗
About INSMED Inc
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersBRIDGEWATER, NJ
IncorporatedVA
SEC CIK0001104506 ↗


